L N Prakhova
6PUBLICATIONS
33CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Apr 27, 2024
[Long-term efficacy and safety of divozilimab during 2-year treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS].A N Boyko, V M Alifirova, I G Lukashevich
|Aug 10, 2023
[Efficacy and safety of antiCD20 monoclonal antibody divozilimab during 48-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS].A N Boyko, V M Alifirova, I G Lukashevich
|Apr 21, 2023
[Efficacy and safety of divozilimab during 24-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-2].A N Boyko, V M Alifirova, I G Lukashevich
|Aug 01, 2022
[Local experience of IL-6 pathway inhibition with satralizumab for patients with neuromyelitis optica spectrum disorder].L N Prakhova, V S Krasnov, D S Kasatkin
|Jul 29, 2022
[The first russian experience of use of siponimod in real clinical practice].L N Prakhova, A G Ilves
|Jan 15, 2020
[Results of a phase 1 clinical study of anti-CD20 monoclonal antibody (BCD-132): pharmacokinetics, pharmacodynamics and safety].O V Boyko, A N Boyko, P A Yakovlev
Pageof 1
Frequent Collaborators
4 joint publications
A N Boyko
4 joint publications
A V Zinkina-Orikhan
4 joint publications
S V Kotov
4 joint publications
Yu N Linkova
4 joint publications
N A Totolyan
4 joint publications
S G Shchur
3 joint publications
I V Greshnova
3 joint publications
Z A Goncharova
3 joint publications
I G Lukashevich
3 joint publications
V M Alifirova
